- Home
- NMT vs ZTEK Comparison
NMT vs ZTEK Comparison
Compare NMT & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMT
- ZTEK
- Stock Information
- Founded
- NMT 1993
- ZTEK 2008
- Country
- NMT United States
- ZTEK Canada
- Employees
- NMT N/A
- ZTEK N/A
- Industry
- NMT Finance/Investors Services
- ZTEK Major Chemicals
- Sector
- NMT Finance
- ZTEK Industrials
- Exchange
- NMT Nasdaq
- ZTEK Nasdaq
- Market Cap
- NMT 107.6M
- ZTEK 91.6M
- IPO Year
- NMT N/A
- ZTEK N/A
- Fundamental
- Price
- NMT $11.62
- ZTEK $1.01
- Analyst Decision
- NMT
- ZTEK
- Analyst Count
- NMT 0
- ZTEK 0
- Target Price
- NMT N/A
- ZTEK N/A
- AVG Volume (30 Days)
- NMT 19.1K
- ZTEK 837.3K
- Earning Date
- NMT 01-01-0001
- ZTEK 11-13-2025
- Dividend Yield
- NMT 3.21%
- ZTEK N/A
- EPS Growth
- NMT N/A
- ZTEK N/A
- EPS
- NMT N/A
- ZTEK N/A
- Revenue
- NMT N/A
- ZTEK $678,078.00
- Revenue This Year
- NMT N/A
- ZTEK N/A
- Revenue Next Year
- NMT N/A
- ZTEK N/A
- P/E Ratio
- NMT N/A
- ZTEK N/A
- Revenue Growth
- NMT N/A
- ZTEK 2519.47
- 52 Week Low
- NMT $9.05
- ZTEK $0.50
- 52 Week High
- NMT $10.93
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- NMT 63.62
- ZTEK 63.78
- Support Level
- NMT $11.14
- ZTEK $0.65
- Resistance Level
- NMT $11.58
- ZTEK $1.07
- Average True Range (ATR)
- NMT 0.11
- ZTEK 0.12
- MACD
- NMT 0.04
- ZTEK 0.04
- Stochastic Oscillator
- NMT 89.96
- ZTEK 62.90
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.